Literature DB >> 16582930

Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling.

Richard D Hayward1, John M Leong, Vassilis Koronakis, Kenneth G Campellone.   

Abstract

Many microbial pathogens manipulate the actin cytoskeleton of eukaryotic target cells to promote their internalization, intracellular motility and dissemination. Enteropathogenic and enterohaemorrhagic Escherichia coli, which both cause severe diarrhoeal disease, can adhere to mammalian intestinal cells and induce reorganization of the actin cytoskeleton into 'pedestal-like' pseudopods beneath the extracellular bacteria. As pedestal assembly is triggered by E. coli virulence factors that mimic several host cell-signalling components, such as transmembrane receptors, their cognate ligands and cytoplasmic adaptor proteins, it can serve as a powerful model system to study eukaryotic transmembrane signalling. Here, we consider the impact of recent data on our understanding of both E. coli pathogenesis and cell biology, and the rich prospects for exploiting these bacterial factors as versatile tools to probe cellular signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582930     DOI: 10.1038/nrmicro1391

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  44 in total

1.  Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly.

Authors:  Olli Aitio; Maarit Hellman; Arunas Kazlauskas; Didier F Vingadassalom; John M Leong; Kalle Saksela; Perttu Permi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Membrane-deforming proteins play distinct roles in actin pedestal biogenesis by enterohemorrhagic Escherichia coli.

Authors:  Kenneth G Campellone; Anosha D Siripala; John M Leong; Matthew D Welch
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

3.  Molecular characterization of GrlA, a specific positive regulator of ler expression in enteropathogenic Escherichia coli.

Authors:  Rafael Jiménez; Sara B Cruz-Migoni; Alejandro Huerta-Saquero; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2010-07-09       Impact factor: 3.490

4.  Actin pedestal formation by enteropathogenic Escherichia coli is regulated by IQGAP1, calcium, and calmodulin.

Authors:  Matthew D Brown; Lynn Bry; Zhigang Li; David B Sacks
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

Review 5.  Manipulation of host membranes by bacterial effectors.

Authors:  Hyeilin Ham; Anju Sreelatha; Kim Orth
Journal:  Nat Rev Microbiol       Date:  2011-07-18       Impact factor: 60.633

6.  Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs.

Authors:  Dapeng Yan; Xingyu Wang; Lijun Luo; Xuetao Cao; Baoxue Ge
Journal:  Nat Immunol       Date:  2012-09-23       Impact factor: 25.606

7.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

Review 8.  Morphological plasticity of bacteria-Open questions.

Authors:  Jie-Pan Shen; Chia-Fu Chou
Journal:  Biomicrofluidics       Date:  2016-06-10       Impact factor: 2.800

Review 9.  Roles of DNA adenine methylation in host-pathogen interactions: mismatch repair, transcriptional regulation, and more.

Authors:  Martin G Marinus; Josep Casadesus
Journal:  FEMS Microbiol Rev       Date:  2009-01-19       Impact factor: 16.408

10.  Cortactin recruitment by enterohemorrhagic Escherichia coli O157:H7 during infection in vitro and ex vivo.

Authors:  Aurelie Mousnier; Andrew D Whale; Stephanie Schüller; John M Leong; Alan D Phillips; Gad Frankel
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.